The researchers found that the prevalence of chronic pruritus was 8.6%, 10.5%, and 18.6% for current, 12-month, and lifetime prevalence, respectively.

Black Friday is over. Cyber Monday has come and gone. But that doesn't mean the shopping season is over – especially if ...

While documenting life on Hawaii’s Big Island, photographer Josh Cogan follows one man’s path toward reconnection—where food, ...

On November 5, 2025, argenx SE announced that Health Canada approved VYVGART SC (efgartigimod alfa injection) as a monotherapy for adults with active chronic inflammatory demyelinating polyneuropathy ...

Dr. Lin joins Nuvig to advance NVG-2089 through Phase 2 studies in chronic inflammatory demyelinating polyneuropathy and ...

VYVGART ® SC is first and only neonatal Fc receptor blocker approved to treat CIDP Authorization is based on global ADHERE study, the largest clinical trial in CIDP to date First novel, targeted ...

National Geographic photographer Josh Cogan captures the quiet power of Hawaii’s ocean life, revealing how resilience shows ...

Diabetic peripheral neuropathy is a common complication of diabetes, often marked by pain, numbness, weakness and poor ...

The good news is that, with significant late-stage pipeline activity, new early-stage projects, and continued strong ...

Do you have long-term, chronic pain…maybe you feel older than you are? Dr. Lucas Brown, DAOM, LAc with Rosedale Acupuncture ...

“The problem is that vitamin B6 is in a range of products, so it is easy to accidentally take too much without realizing,” ...

A French-American team reports that Carba1 prevents chemotherapy-induced neuropathy in preclinical models while preserving ...